Arpeggio Biosciences

Arpeggio Biosciences
Last activity: 07.09.2022
Categories: MedtechLearnInvestmentDrugDevelopmentBioTechArtificial IntelligenceNetworksPlatformTechnology
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development. We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
Location: United States, Colorado, Boulder
Employees: 1-10
Total raised: $20.2M
Founded date: 2017

Investors 3

Funding Rounds 2

07.09.2022Series A$17M-

Mentions in press and media 3

07.09.2022Arpeggio Biosciences Raises $17M in Series A FundingArpeggio Biosciences, a Boulder, CO-based preclinical therapeutics company whose technology targets
07.09.2022Arpeggio Biosciences rakes in $17M to measure the transcript...How can drug developers design therapies around cellular networks rather than a single target? That...medcitynew...
15.01.2020Arpeggio Bio Secures USD 3.2M in Seed FundingArpeggio Bio , a Boulder, Colo.-based preclinical company whose technology provides a mechanistic

Reviews 0

Sign up to leave a review

Sign up Log In